Ajanta Pharma USA Inc recalls
Ajanta Pharma USA Inc is named on 4 recalls in Recall Relay's records since November 2023, from FDA; the most recent was September 17, 2026.
All 4, newest first.
-
Class IIofficial
Ajanta Pharma USA Inc recalls Ranolazine Extended-Release TabletsFailed Dissolution Specifications: below specification
-
Class IIIofficial
Ajanta Pharma USA Inc recalls Fluphenazine Hydrochloride TabletsFailed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 percent.
-
Class IIofficial
Ajanta Pharma USA Inc recalls Fenofibrate CapsulesCGMP Deviations
-
Class IIofficial
Ajanta Pharma USA Inc recalls Aripiprazole Tablets USPProduct Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions Ajanta Pharma USA Inc or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts